Contact-free continuous monitoring (CFCM) will reach an estimated $15 billion per year level in the US market, according to a new Frost & Sullivan Report.

“These studies show that continuous monitoring presents a unique opportunity to create both top and bottom line benefits, while simultaneously improving quality of care,” said Charlie Whelan, Frost & Sullivan’s Transformational Health North America Consulting Director. “Our findings indicate there are approximately 750,000 currently unmonitored medical/surgical beds in the U.S., and that the economic potential of adopting CFCM is a game-changer, in terms of changing patient outcomes, shortening hospital stays and improving economics.”

EarlySense, commenting on the report, said each hospital bed it is monitoring is saving more than $19,000 by using its technology. The technology and its savings may impact long-term care providers entering a bundled payment partnership.

“We are excited to continue to offer the most advanced CFCM solutions to our customers in the U.S. and abroad, and to expand our reach to new facilities to help achieve positive patient outcomes and improved economics for the healthcare system,” said Avner Halperin, CEO of EarlySense.